Facility Design and Engineering

May 16, 2018
By BioPharm International Editors
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
May 01, 2018
BioPharm International
More published data and initial regulatory approvals are needed to drive adoption of continuous bio-manufacturing.
Apr 17, 2018
By BioPharm International Editors
The company is launching a new pre-fabricated, ready-to-run manufacturing facility that is expected to significantly decrease the production timeline for viral vector-based therapeutics.
Apr 12, 2018
By BioPharm International Editors
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
Apr 11, 2018
By BioPharm International Editors
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
Apr 10, 2018
By BioPharm International Editors
The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.
Mar 22, 2018
By BioPharm International Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
Mar 20, 2018
By BioPharm International Editors
ISPE announced BioMarin Pharmaceutical, Shire, Vetter, and Wyeth Pharmaceuticals as FOYA Category winners.
Mar 15, 2018
BioPharm International
A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.
Mar 05, 2018
By BioPharm International Editors
JLL, a real estate and investment management firm, recently released a new report on three trends shaping labs for the future of life sciences R&D.
native1_300x100
lorem ipsum